Dentinal Hypersensitivity Clinical Trial
Official title:
: Clinical Study to Assess the Efficacy of a Dentifrice Containing Stannous Fluoride as Compared to a Commercially-available Potassium-based Toothpaste and a Regular Fluoride Toothpaste (Negative Control) on the Reduction of Dentinal Hypersensitivity.
Verified date | January 2024 |
Source | Colgate Palmolive |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this clinical study is to assess the efficacy of a dentifrice containing stannous fluoride (Colgate-Palmolive Company, New York, NY, USA) as compared to a commercially-available potassium-based toothpaste (Sensodyne Extra Whitening Toothpaste, GlaxoSmithKline Co., UK) and a commercially available non-desensitizing toothpaste (Colgate Cavity Protection Toothpaste, Colgate-Palmolive Company, New York, NY, USA) in the reduction of dentinal hypersensitivity over a seven (7) day period.
Status | Completed |
Enrollment | 123 |
Est. completion date | October 21, 2020 |
Est. primary completion date | October 21, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - Sign an Informed Consent Form; - Male or female 18 to 70 years of age, inclusive; - Be in good general health as determined by the study investigators; - Available for the seven (7) days duration of the study; - Must present two (2) sensitive teeth which must meet ALL of the following criteria: - Be anterior to the molars and demonstrating dentin exposure due to cervical erosion/abrasion and/or gingival recession; - Have a qualifying dentin hypersensitivity response to tactile stimuli applied to the cervical surface (gingivo-facial 1/3) as defined by a response score between 10- 50grams of force (Yeaple Probe, XiniX Research Inc. Portsmouth, NH, USA); - Have a qualifying dentin hypersensitivity response to air blast stimuli applied for one second to the cervical surface (gingivo-facial 1/3) as defined by a score of 2 or 3 on the Schiff Cold Air Sensitivity Scale Exclusion Criteria: - Gross oral pathology, chronic disease, and/or history of allergies to any of the test products; - Use of a desensitizing oral care product and/or recipient of any dental desensitizing treatment within the past three months prior to start of the study; - Advanced periodontal disease and/or treatment for periodontal disease (including surgery) within the past twelve months; - Sensitive teeth with a mobility greater than one; - Teeth with extensive/defective restorations (including prosthetic crowns), suspected pulpitis, caries, cracked enamel, or used as abutments for removable partial dentures; - Current use of anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory drugs, or daily use of analgesics; - Participation in any other oral clinical study for the duration of this study - Self-reported pregnancy and/or currently breastfeeding; - Allergies to oral care products, personal care consumer products, and/or their ingredients; - Medical condition which prohibits not eating/drinking for 4 hours. |
Country | Name | City | State |
---|---|---|---|
United States | Mesa Dental Centre | Costa Mesa | California |
Lead Sponsor | Collaborator |
---|---|
Colgate Palmolive |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Tactile dentin hypersensitivity | Have a qualifying dentin hypersensitivity response to tactile stimuli applied to the cervical surface (gingivo-facial 1/3) as defined by a response score between 10- 50grams of force (Yeaple Probe, XiniX Research Inc. Portsmouth, NH, USA) | Baseline, 1-Day, 3-Days and 7-Days | |
Primary | Air blast dentin hypersensitivity | Have a qualifying dentin hypersensitivity response to air blast stimuli applied for one second to the cervical surface (gingivo-facial 1/3) as defined by a score of 2 or 3 on the Schiff Cold Air Sensitivity Scale. | Baseline, 1-Day, 3-Days and 7-Days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02466945 -
Oral and Dental Tolerance and Efficacy on Dentinal Hypersensitivity of a Dental Gel, on Adults
|
N/A | |
Completed |
NCT06166745 -
Efficacy of Sensi-IP Toothpaste in the Treatment of Dentinal Hypersensitivity Compared to a Sodium Fluoride Toothpaste
|
N/A | |
Completed |
NCT02613117 -
Research on Oral Tolerability and Product Application/Response of Two Oxalate Products for Dental Patients With Risk of Dentinal Hypersensitivity
|
N/A | |
Recruiting |
NCT05852366 -
Efficacy of Herbal Dentifrice for Management of Dentinal Hypersensitivity
|
Phase 3 | |
Completed |
NCT03405259 -
A Clinical Study to Compare Professional Treatments for Dentinal Hypersensitivity
|
N/A | |
Completed |
NCT02008500 -
Comparison Of Clinical Efficacy Of A Herbal And A Non-Herbal Mouthwash On Dentinal Hypersensitivity
|
Phase 2 | |
Completed |
NCT01831817 -
Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity
|
Phase 2 | |
Completed |
NCT04091256 -
Treatment of Tooth Sensitivity With the Use of Biorepair Toothpaste
|
N/A | |
Completed |
NCT01587950 -
The Effects of Potassium Nitrate in Reducing Dentinal Hypersensitivity
|
Phase 1 | |
Completed |
NCT03738514 -
Comparison of Efficacy of 5% Fluorocalcium Phosphosilicate Dentifrice and Potassium Nitrate Dentifrice on Dentinal Hypersensitivity
|
Phase 2 | |
Completed |
NCT03741309 -
Comparison of Clinical Efficacy of a Dentifrice Containing 5% Fluoro Calcium Phosphosilicate to a Dentifrice Containing Calcium Sodium Phosphosilicate on Dentinal Hypersensitivity
|
Phase 2 | |
Recruiting |
NCT03553290 -
Therapeutic Evaluation of Lower-level Laser for Treating Dentinal Hypersensitivity
|
N/A |